/CNW/ - Seagen Canada has entered into a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) regarding TUKYSA, a tyrosine kinase.
Genetic tools help identify a cellular culprit for type 1 diabetes eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.